Jim Simons Ironwood Pharmaceuticals Inc Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 9,940,492 shares of IRWD stock, worth $5.67 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,940,492
Previous 9,066,241
9.64%
Holding current value
$5.67 Million
Previous $40.2 Million
63.62%
% of portfolio
0.02%
Previous 0.06%
Shares
25 transactions
Others Institutions Holding IRWD
# of Institutions
222Shares Held
166MCall Options Held
11.2MPut Options Held
6.9K-
Black Rock Inc. New York, NY22.9MShares$13 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$9.34 Million6.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$8.95 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY13.7MShares$7.81 Million0.31% of portfolio
-
Braidwell LP Stamford, CT6.62MShares$3.77 Million0.6% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $87.3M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...